FDA Approves First New Drug With International Group FDA Approves First New Drug With International Group

The approval is for the oral therapy tucatinib (Tukysa, Seattle Genetics) for the treatment of advanced HER2-positive breast cancer.FDA Approvals

Source: Medscape Hematology-Oncology Headlines - April 17, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news